Cannabinoid-1 receptor gene deletion has a compartment-specific affect on the dendritic and axonal availability of μ-opioid receptors and on dopamine axons in the mouse nucleus accumbens

Synapse

Volumn 64, Issue 12, 2010, Pages 886-897

  Lane, Diane A ^a   Chan, June ^a   Lupica, Carl R ^b   Pickel, Virginia M ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Development; Drug addiction; Immunolabeling; Mouse; Reward

Indexed keywords

CANNABINOID 1 RECEPTOR; MU OPIATE RECEPTOR; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MEMBRANE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CYTOPLASM; DENDRITIC CELL; DENDRITIC SPINE; GENE DELETION; IMMUNOELECTRON MICROSCOPY; IMMUNOGOLD LABELING; IMMUNOPEROXIDASE STAINING; NERVE ENDING; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; AXONS; CELL COMPARTMENTATION; DENDRITES; DOPAMINE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NUCLEUS ACCUMBENS; RECEPTOR, CANNABINOID, CB1; RECEPTORS, OPIOID, MU;

EID: 77958162949     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20807     Document Type: Article

References (57)

1. Afify EA., Law PY., Riedl M., Elde R., Loh HH..1998.Role of carboxyl terminus of μ- and δ-opioid receptor in agonist-induced down-regulation.Mol Brain Res54:24-34.
2. Arden JR., Segredo V., Wang Z., Lameh J., Sadee W..1995.Phosphorylation and agonist-specific intracellular trafficking of an epitope-tagged μ-opioid receptor expressed in HEK 293 cells.J Neurochem65:1636-1645.
3. Arvidsson U., Riedl M., Chakrabarti S., Lee J-H., Nakano AH., Dado RJ., Loh HH., Law P-Y., Wessendorf MW., Elde R..1995.Distribution and targeting of a μ-opioid receptor (MOR1) in brain and spinal cord.J Neurosci15:3328-3341.
4. Aubert I., Ghorayeb I., Normand E., Bloch B..2000.Phenotypical characterization of the neurons expressing the D1 and D2 dopamine receptors in the monkey striatum.J Comp Neurol418:22-32.
5. Basavarajappa BS., Nixon RA., Arancio O..2009.Endocannabinoid system: Emerging role from neurodevelopment to neurodegeneration.Mini Rev Med Chem9:448-462.
6. Bonnin A., De Miguel R., Hernandez ML., Ramos JA., Fernandez-Ruiz JJ..1995.The prenatal exposure to δ9-tetrahydrocannabinol affects the gene expression and the activity of tyrosine hydroxylase during early brain development.Life Sci56:2177-2184.
7. Bramham CR., Sarvey JM..1996.Endogenous activation of μ and δ-1 opioid receptors is required for long-term potentiation induction in the lateral perforant path: Dependence on GABAergic inhibition.J Neurosci16:8123-8131.
8. Calverley RKS., Jones DG..1990.Contributions of dendritic spines and perforated synapses to synaptic plasticity.Brain Res Rev15:215-249.
9. Chan J., Aoki C., Pickel VM..1990.Optimization of differential immunogold-silver and peroxidase labeling with maintenance of ultrastructure in brain sections before plastic embedding.J Neurosci Methods33:113-127.
10. Chen Y., Mestek A., Liu J., Hurley JA., Yu L..1993.Molecular cloning and functional expression of a μ-opioid receptor from rat brain.Mol Pharmacol44:8-12.
11. Di Chiara G., Bassareo V..2007.Reward system and addiction: What dopamine does and doesn't do.Curr Opin Pharmacol7:69-76.
12. Di Chiara G., Bassareo V., Fenu S., De Luca MA., Spina L., Cadoni C., Acquas E., Carboni E., Valentini V., Lecca D..2004.Dopamine and drug addiction: The nucleus accumbens shell connection.Neuropharmacology47 (Suppl 1):227-241.
13. Duarte C., Alonso R., Bichet N., Cohen C., Soubrie P., Thiebot MH..2004.Blockade by the cannabinoid CB1 receptor antagonist, rimonabant (SR141716), of the potentiation by quinelorane of food-primed reinstatement of food-seeking behavior.Neuropsychopharmacology29:911-920.
14. Fernandez-Ruiz J., Gomez M., Hernandez M., De Miguel R., Ramos JA..2004.Cannabinoids and gene expression during brain development.Neurotox Res6:389-401.
15. Franklin KBJ., Paxinos G..1997.The mouse brain in stereotaxic coordinates.San Diego:Academic Press.
16. Fride E., Gobshtis N., Dahan H., Weller A., Giuffrida A., Ben-Shabat S..2009.The endocannabinoid system during development: Emphasis on perinatal events and delayed effects.Vitam Horm81:139-158.
17. Gardner EL., Vorel SR..1998.Cannabinoid transmission and reward-related events.Neurobiol Dis5(6, Pt B):502-533.
18. Gracy KN., Svingos AL., Pickel VM..1997.Dual ultrastructural localization of μ-opioid receptors and NMDA-type glutamate receptors in the shell of the rat nucleus accumbens.J Neurosci17:4839-4848.
19. Heimer L., Alheid GF., De Olmos JS., Groenewegen HJ., Haber SN., Harlan RE., Zahm DS..1997.The accumbens: Beyond the core-shell dichotomy.J Neuropsychiatry Clin Neurosci9:354-381.
20. Hoffman AF., Lupica CR..2001.Direct actions of cannabinoids on synaptic transmission in the nucleus accumbens: A comparison with opioids.J Neurophysiol85:72-83.
21. Hoffman AF., Oz M., Caulder T., Lupica CR..2003.Functional tolerance and blockade of long-term depression at synapses in the nucleus accumbens after chronic cannabinoid exposure.J Neurosci23:4815-4820.
22. Jardinaud F., Crete D., Canestrelli C., Ledent C., Roques BP., Noble F..2005.CB1 receptor knockout mice show similar behavioral modifications to wild-type mice when enkephalin catabolism is inhibited.Brain Res1063:77-83.
23. Jones DG., Harris RJ..1995.An analysis of contemporary morphological concepts of synaptic remodelling in the CNS: Perforated synapses revisited.Rev Neurosci6:177-219.
24. Kalivas PW., Churchill L., Klitenick MA..1993.GABA and enkephalin projection from the nucleus accumbens and ventral pallidum to the ventral tegmental area.Neurosci57:1047-1060.
25. Ledent C., Valverde O., Cossu G., Petitet F., Aubert JF., Beslot F., Bohme GA., Imperato A., Pedrazzini T., Roques BP., Vassart G., Fratta W., Parmentier M..1999.Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice.Science283:401-404.
26. Leranth C., Pickel VM..1989.Electron microscopic pre-embedding double immunostaining methods. In:Heimer L., Zaborszky L., editors.Neuroanatomical tract-tracing methods, Part 2: Recent progress, 1st ed.New York:Plenum. p129-172.
27. Lessard A., Pickel VM..2005.Subcellular distribution and plasticity of neurokinin-1 receptors in the rat substantia nigra and ventral tegmental area.Neuroscience135:1309-1323.
28. Li X., Hoffman AF., Peng XQ., Lupica CR., Gardner EL., Xi ZX..2009.Attenuation of basal and cocaine-enhanced locomotion and nucleus accumbens dopamine in cannabinoid CB1-receptor-knockout mice.Psychopharmacology (Berl)204:1-11.
29. Liao D., Lin H., Law PY., Loh HH..2005.μ-Opioid receptors modulate the stability of dendritic spines.Proc Natl Acad Sci USA102:1725-1730.
30. Mansour A., Fox CA., Burke S., Meng F., Thompson RC., Akil H., Watson SJ..1994.Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: An in situ hybridization study.J Comp Neurol350:412-438.
31. Mansour A., Fox CA., Burke S., Akil H., Watson SJ..1995.Immunohistochemical localization of the cloned μ-opioid receptor in the rat CNS.J Chem Neuroanat8:283-305.
32. Mato S., Chevaleyre V., Robbe D., Pazos A., Castillo PE., Manzoni OJ..2004.A single in-vivo exposure to δ9THC blocks endocannabinoid-mediated synaptic plasticity.Nat Neurosci7:585-586.
33. Martin M., Ledent C., Parmentier M., Maldonado R., Valverde O..2002.Involvement of CB1 cannabinoid receptors in emotional behaviour.Psychopharmacology (Berl)159:379-387.
34. Navarro M., Carrera MR., Fratta W., Valverde O., Cossu G., Fattore L., Chowen JA., Gomez R., del Arco I., Villanua MA., Maldonado R., Koob GF., De Fonseca FR..2001.Functional interaction between opioid and cannabinoid receptors in drug self-administration.J Neurosci21:5344-5350.
35. Nikoshkov A., Drakenberg K., Wang X., Horvath MC., Keller E., Hurd YL..2008.Opioid neuropeptide genotypes in relation to heroin abuse: Dopamine tone contributes to reversed mesolimbic proenkephalin expression.Proc Natl Acad Sci USA105:786-791.
36. Nirenberg MJ., Vaughan RA., Uhl GR., Kuhar MJ., Pickel VM..1996.The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons.J Neurosci16:436-447.
37. Nirenberg MJ., Chan J., Pohorille A., Vaughan RA., Uhl GR., Kuhar MJ., Pickel VM..1997.The dopamine transporter: Comparative ultrastructure of dopaminergic axons in limbic and motor compartments of the nucleus accumbens.J Neurosci17:6899-6907.
38. Nugent FS., Penick EC., Kauer JA..2007.Opioids block long-term potentiation of inhibitory synapses.Nature446:1086-1090.
39. Peters A., Palay SL., Webster Hd..1991.The fine structure of the nervous system, 3 ed.New York:Oxford University Press.1 p.
40. Pickel VM., Colago EEO..1999.Presence of μ-opioid receptors in targets of efferent projections from the central nucleus of the amygdala to the nucleus of the solitary tract.Synapse33:141-152.
41. Pickel VM., Chan J., Kash TL., Rodriguez JJ., Mackie K..2004.Compartment-specific localization of cannabinoid 1 (CB1) and μ-opioid receptors in rat nucleus accumbens.Neuroscience127:101-112.
42. Reynolds ES..1963.The use of lead citrate at high pH as an electron-opaque stain in electron microscopy.J Cell Biol17:208.
43. Robbe D., Alonso G., Duchamp F., Bockaert J., Manzoni OJ..2001.Localization and mechanisms of action of cannabinoid receptors at the glutamatergic synapses of the mouse nucleus accumbens.J Neurosci21:109-116.
44. Robbe D., Kopf M., Remaury A., Bockaert J., Manzoni OJ..2002.Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens.Proc Natl Acad Sci USA99:8384-8388.
45. Rodriguez JJ., Mackie K., Pickel VM..2001.Ultrastructural localization of the CB1 cannabinoid receptor in μ-opioid receptor patches of the rat Caudate putamen nucleus.J Neurosci21:823-833.
46. Steiner H., Bonner TI., Zimmer AM., Kitai ST., Zimmer A..1999.Altered gene expression in striatal projection neurons in CB1 cannabinoid receptor knockout mice.Proc Natl Acad Sci USA96:5786-5790.
47. Sternini C., Brecha NC., Minnis J., D'Agostino G., Balestra B., Fiori E., Tonini M..2000.Role of agonist-dependent receptor internalization in the regulation of mu opioid receptors.Neurosci98:233-241.
48. Svingos AL., Moriwaki A., Wang JB., Uhl GR., Pickel VM..1997.μ-Opioid receptors are localized to extrasynaptic plasma membranes of GABAergic neurons and their targets in the rat nucleus accumbens.J Neurosci17:2585-2594.
49. Svingos AL., Garzón M., Colago EE., Pickel VM..2001.μ-Opioid receptors in the ventral tegmental area are targeted to presynaptically and directly modulate mesocortical projection neurons.Synapse41:221-229.
50. Valverde O., Ledent C., Beslot F., Parmentier M., Roques BP..2000.Reduction of stress-induced analgesia but not of exogenous opioid effects in mice lacking CB1 receptors.Eur J Neurosci12:533-539.
51. Valverde O., Noble F., Beslot F., Dauge V., Fournie-Zaluski MC., Roques BP..2001.δ9-Tetrahydrocannabinol releases and facilitates the effects of endogenous enkephalins: Reduction in morphine withdrawal syndrome without change in rewarding effect.Eur J Neurosci13:1816-1824.
52. Wang H., Cuzon VC., Pickel VM..2003.Postnatal development of μ-opioid receptors in the rat caudate-putamen nucleus parallels asymmetric synapse formation.Neuroscience118:695-708.
53. Yang SN., Lippoldt A., Jansson A., Phillips MI., Ganten D., Fuxe K..1997.Localization of angiotensin II AT1 receptor-like immunoreactivity in catecholaminergic neurons of the rat medulla oblongata.Neuroscience81:503-515.
54. Zahm DS..1999.Functional-anatomical implications of the nucleus accumbens core and shell subterritories.Ann NY Acad Sci877:113-128.
55. Zahm DS..2000.An integrative neuroanatomical perspective on some subcortical substrates of adaptive responding with emphasis on the nucleus accumbens.Neurosci Biobehav Rev24:85-105.
56. Zaki PA., Keith DE.Jr, Brine GA., Carroll FI., Evans CJ..2000.Ligand-induced changes in surface μ-opioid receptor number: Relationship to G protein activation?J Pharmacol Exp Ther292:1127-1134.
57. Zimmer A., Zimmer AM., Hohmann AG., Herkenham M., Bonner TI..1999.Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice.Proc Natl Acad Sci USA96:5780-5785.